Arkadios Wealth Advisors - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 75 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Arkadios Wealth Advisors ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$87,555
-2.4%
150,000
+50.0%
0.01%
-14.3%
Q1 2024$89,730
+18.1%
100,000
-80.6%
0.01%
+16.7%
Q4 2023$75,964
+10.5%
515,0000.0%0.01%0.0%
Q3 2023$68,724515,0000.01%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 498,783$3940.05%
Inspire Advisors, LLC 195,946$154,7970.04%
Wealth Advisory Solutions, LLC 155,850$123,1220.03%
Miller Investment Management, LP 50,000$39,5000.01%
Virtu Financial LLC 39,005$310.00%
Pasadena Private Wealth, LLC 10,965$8,6620.00%
Jump Financial, LLC 49,251$38,9080.00%
Qube Research & Technologies Ltd 120,580$95,2580.00%
TWO SIGMA SECURITIES, LLC 61,613$48,6740.00%
Kestra Advisory Services, LLC 93,717$74,0360.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders